Wexleret al. found that the mean scores on the Quality of Life Adult Growth Hormone Deficiency Assessment (QoL-AGHDA), SF-36, and Symptom Questionnaire Depression showed significantly impaired QoL in the GH-deficient group when compared with the GH-sufficient group. Here, GH1 is linked to depressive symptom measurement.